Physician profile
David Miles
NPI 1831198738
$1,446.22
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $762 · 2020: $124 · 2021: $239 · 2022: $321.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $529.97 | 2019-2020 | |
| Medtronic, INC. | $475.11 | 2021-2022 | |
| Ethicon US, LLC | $221.98 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $108.18 | 2019-2021 | |
| Intra-Sana Laboratories | $48.63 | 2021 | |
| Daiichi Sankyo INC. | $24.25 | 2020-2021 | |
| Novo Nordisk INC | $23.50 | 2019-2020 | |
| Karl Storz Endoscopy-America | $14.60 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.